Evidence for early and persistent impairment of salivary gland excretion after irradiation of head and neck tumours

European Journal of Nuclear Medicine

Volumn 23, Issue 11, 1996, Pages 1485-1490

  Liem, Ing Han ^a   Valdés Olmos, Renato A ^a   Balm, Alfons J M ^a   Keus, Ronald B ^a   Van Tinteren, Harm ^a   Takes, Robert P ^a   Muller, Sara H ^a   Bruce, Allison M ^a   Hoefnagel, Cornelis A ^a   Hilgers, Frans J ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Head and neck malignancies; Radiotherapy; Salivary gland dysfunction; Technetium 99m pertechnetate salivary gland scintigraphy; Xerostomia

Indexed keywords

CARBACHOL; PERTECHNETIC ACID TC 99M;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CANCER; HUMAN; HYPOSALIVATION; MALE; PAROTID GLAND; RADIATION DOSE; SALIVARY GLAND SCINTISCANNING; SUBMANDIBULAR GLAND; XEROSTOMIA;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RADIATION INJURIES; SALIVARY GLAND DISEASES; SALIVARY GLANDS; SALIVATION; SODIUM PERTECHNETATE TC 99M; TIME FACTORS; XEROSTOMIA;

EID: 10344262016     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01254473     Document Type: Article

References (19)

1. Tsujii H. Quantitative dose-response analysis of salivary function following radiotherapy using sequential ri-sialography. Int J Radiat Oncol Biol Phys 1985; 11: 1603-1612.
2. Wiesenfeld D, Webster G, Cameron F, Ferguson MM, MacFadyen EE, MacFarlane TW. Salivary gland dysfunction following radioactive iodine therapy. Oral Surg Oral Med Oral Pathol 1983; 55: 138-141.
3. Leslie MD, Dische S. The early changes in salivary gland function during and after radiotherapy given for head and neck cancer. Radiother Oncol 1994; 30: 26-32.
4. Jansma J, Vissink A, Spijkervet FKL, et al. Protocol for the prevention and treatment of oral sequelae resulting from head and neck radiation therapy. Cancer 1992; 70: 2171-2180.
5. 99mTc-scintigraphy: a grading scale and correlation with major salivary gland flow rates. J Oral Pathol Med 1992; 21: 70-74.
6. Valdés Olmos RA, Keus RB, Takes RP, van Tinteren H, Baris G, Hilgers FJ, Hoefnagel CA, Balm AJ. Scintigraphic assessment of salivary function and excretion response in radiation-induced injury of the major salivary glands. Cancer 1994; 73: 2886-2893.
7. Watkinson JC. Nuclear medicine in otolaryngology. Clin Otolaryngol 1990; 15: 457-469.
8. Valdez IH, Atkinson JC, Ship JA, Fox PC. Major salivary gland function in patients with radiation-induced xerostomia: flow rates and sialochemistry. Int J Radiat Oncol Biol Phys 1993; 25: 41-47.
9. Franzen L, Funegard U, Ericson T, Henriksson R. Parotid gland function during and following radiotherapy of malignancies in the head and neck, a consecutive study of salivary flow and patient discomfort. Eur J Cancer 1992; 28: 457-462.
10. Murkitziu A, Zafiropoulos G, Tsalikis L, Cohen L. Gingival health and salivary funtion in head and neck-irradiated patients, a five-year follow-up. Oral Surg Oral Med Oral Pathol 1992; 73: 427-433.
11. Wolff A, Atkinson JC, Macynski AA, Fox PC. Pretherapy interventions to modify salivary dysfunction. NCI Monogr 1990; 9: 87-90.
12. Bohuslavizki KH, Brenner W, Wolf H, Sippel C, Tonshoff G, Tinnemeyer S, Clausen M, Henze E. Value of quantitative salivary gland scintigraphy in the early stage of Sjögren's syndrome. Nucl Med Commun 1995; 16: 917-922.
13. Bohuslavizki KH, Karde P, Winter M, Sippel S, Tinnemeyer S, Brenner W, Wolf H, Schramm M, Stauch C, Clausen M, Henze E. Standardized uptake and excretion fraction in salivary glands derived from 116 normals [abstract]. Eur J Nucl Med 1995; 22: 801.
14. Stephens LC, Schultheiss TE, Price RE, Ang KK, Peters LJ. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Cancer 1991; 67: 1539-1543.
15. LeVeque FG, Montgomery M, Potter D, Zimmer MB, Rieke JW, Steiger BW, Gallagher SC, Muscoplat CC. A multicenter, randomized, double blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer. J Clin Oncol 1993; 11: 1124-1131.
16. Milne RW, Dawes C. The relative contributions of different salivary glands to the blood group activity of whole saliva in humans. Vox Sang 1973; 25: 298-307.
17. Rieke JW, Hafermann MD, Johnson JT, LeVeque FG, Iwamoto R, Steiger BW, Muscoplat C, Gallagher SC. Oral pilocarpine for radiation-induced xerostomia: integrated efficacy and safety results from two prospective randomized clinical trials. Int J Radiat Oncol Biol Phys 1995; 31: 661-669.
18. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, Muscoplat CC, Gallagher SC. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med 1993; 329: 390-395.
19. Valdez IH, Wolff A, Atkinson JC, Macynski AA, Fox PC. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary dysfunction. Cancer 1993; 71: 1848-1851.